Seven Eight Capital, LP Invitae Corp Transaction History

Seven Eight Capital, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$6.28 - $15.59 $204,200 - $506,924	-32,516 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $63,548 - $123,940	-4,323 Reduced 11.73%	32,516 $497,000
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $895,556 - $1.24 Million	36,839 New	36,839 $1.05 Million
Q4 2020 Feb 09, 2021	SELL	$39.09 - $57.4 $376,944 - $553,508	-9,643 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$28.43 - $44.67 $274,150 - $430,752	9,643 New	9,643 $418,000
Q4 2019 Feb 13, 2020	SELL	$15.02 - $20.57 $502,809 - $688,601	-33,476 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $631,022 - $920,590	33,476 New	33,476 $645,000
Q4 2018 Feb 14, 2019	SELL	$9.26 - $16.38 $389,846 - $689,598	-42,100 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$7.54 - $18.31 $317,434 - $770,851	42,100 New	42,100 $704,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.